Expertise in
2
conditions

Dr. William J. Burke

Psychiatry
988102 Nebraska Medical Ctr, 
Omaha, NE 
Accepting New Patients
Expertise in
2
conditions
988102 Nebraska Medical Ctr, 
Omaha, NE 

Overview

William Burke is a Psychiatrist in Omaha, Nebraska. Dr. Burke is highly rated in 2 conditions, according to our data. His top areas of expertise are Dementia, Alzheimer's Disease, Major Depression, and Delirium. Dr. Burke is currently accepting new patients.

His clinical research consists of co-authoring 37 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Psychiatry

Licenses

Geriatric Psychiatry in NE

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

988102 Nebraska Medical Ctr, Omaha, NE 68198

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Prevention of Depression in Patients Being Treated for Head and Neck Cancer
Prevention of Depression in Patients Being Treated for Head and Neck Cancer
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 4
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of BIIB092 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety, Tolerability, and Efficacy of BIIB092 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: BIIB092
Study Phase: Phase 2
Assessment of Safety, Tolerability, and Efficacy of LY3303560 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of LY3303560 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: LY3303560
Study Phase: Phase 2
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Drug
Study Drug: Tilavonemab
Study Phase: Phase 2
A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer's Disease Dementia (Extension of Study AZES, The AMARANTH Study)
A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer's Disease Dementia (Extension of Study AZES, The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 3
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: October 10, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

37 Total Publications

Human-Animal Chimera Formation for Organ Transplantation: Subjugating Human Embryonic Development to Animal Control.
Human-Animal Chimera Formation for Organ Transplantation: Subjugating Human Embryonic Development to Animal Control.
Journal: The Linacre quarterly
Published: June 16, 2023
Similar Doctors
William A. Marcil
Expertise in
9
conditions
Dr. William A. Marcil
Psychiatry | Psychology
Expertise in
9
conditions
Dr. William A. Marcil
Psychiatry | Psychology

CHI Health Clinic Psychiatric Associates (Immanuel Suite 311)

7101 Newport Ave, Medical Office Building Three, Ste 311, 
Omaha, NE 
 (5.1 miles away)
402-572-2916
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

William Marcil is a Psychiatrist and a Psychologist in Omaha, Nebraska. Dr. Marcil is highly rated in 9 conditions, according to our data. His top areas of expertise are Bipolar Disorder (BPD), Schizoaffective Disorder, Major Depression, and Seasonal Affective Disorder (SAD). Dr. Marcil is currently accepting new patients.

Arun Sharma
Expertise in
6
conditions
Dr. Arun Sharma
Psychiatry | Psychology
Expertise in
6
conditions
Dr. Arun Sharma
Psychiatry | Psychology

CHI Health Clinic Psychiatric Associates (Immanuel Suite 207)

7101 Newport Ave, Medical Office Building Three, Ste 207, 
Omaha, NE 
 (5.1 miles away)
402-572-2916
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Arun Sharma is a Psychiatrist and a Psychologist in Omaha, Nebraska. Dr. Sharma is highly rated in 6 conditions, according to our data. His top areas of expertise are Seasonal Affective Disorder (SAD), Major Depression, Bipolar Disorder (BPD), and Schizoaffective Disorder. Dr. Sharma is currently accepting new patients.

Rajesh R. Tampi
Expertise in
10
conditions
Dr. Rajesh R. Tampi
Psychiatry | Psychology
Expertise in
10
conditions
Dr. Rajesh R. Tampi
Psychiatry | Psychology

CHI Health Clinic Psychiatric Associates (Lasting Hope)

415 S 25th Ave, 
Omaha, NE 
 (1.4 miles away)
402-717-5550
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rajesh Tampi is a Psychiatrist and a Psychologist in Omaha, Nebraska. Dr. Tampi is highly rated in 10 conditions, according to our data. His top areas of expertise are Bipolar Disorder (BPD), Seasonal Affective Disorder (SAD), Major Depression, and Dementia. Dr. Tampi is currently accepting new patients.

Frequently Asked Questions about Dr. William J. Burke

How do I make an appointment with Dr. William J. Burke?

You can book an appointment with Dr. William J. Burke by calling their office at 402-559-9600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. William J. Burke a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. William J. Burke is classified as an Advanced expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. William J. Burke specialize in?

While Dr. William J. Burke is a Psychiatry, they have specific expertise in Dementia, Alzheimer's Disease, and Major Depression. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. William J. Burke participate in research or clinical trials?

Yes. Dr. William J. Burke has published 37 articles and abstracts on conditions like Dementia. You can view a list of Dr. William J. Burke's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Burke's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile